Setrusumab
Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer[1].
Product Specifications
CAS Number
[1847394-95-9]
Product Name Alternative
BPS 804
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/setrusumab.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
[Setrusumab]
Molecular Weight
(143.44 kDa)
References & Citations
[1]Hesse E, et al. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight. 2019 Apr 9;5 (9) :e125543.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040325-AP 200 µL
PPM1F, ID (PPM1F, KIAA0015, POPX2, Protein phosphatase 1F, Ca (2+) /calmodulin-dependent protein kinase phosphatase, Partner of PIX 2, Protein fem-2 homolog) (AP) discontinued
Ask
View Details 